Objective. To determine the incidence and identify the clinical-morphological risk factors for the development of epileptic seizures in patients with glial and metastatic brain tumors. Materials and methods. The study included 225 patients (88.6%) with glial and 29 (11.4%) with metastatic brain tumors. Results. Statistically significant differences in the incidence of epileptic seizures depending on age and histological characteristics of tumors, level of malignancy, location, involvement of the cerebral cortex, and displacement of midline structures were found. Conclusions. Epilepsy and epileptic seizures developed in 51.11% and 24.14% cases of glial and metastatic brain tumors, respectively. Risk factors for epileptic seizures were younger age (up to 57 years), histological characteristics corresponding to diffuse astrocytoma, anaplastic astrocytoma, oligodendroglioma, and oligoastrocytoma, malignancy grades I–III, lesions to the temporal lobe, and involvement of the cerebral cortex. Factors decreasing the risk of seizures were age over 57 years, histological characteristics corresponding to glioblastoma, metastatic tumors, malignancy grade IV, subcortical location of neoplasm, lesions to the occipital cortex, involvement of the conducting tracts (commissures) in the pathological process, subtentorial tumor location, absence of lesion in the temporal and frontal lobes of the brain, involvement of both hemispheres of the brain in the pathological process, lesions of two or more lobes of the brain, and displacement of midline structures.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
M. L. Bondy, M. E. Scheurer, B. Malmer, et al., “Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium (BTEC),” Cancer, 113, Suppl. 7, 1953–1968 (2008), https://doi.org/10.1002/cncr.23741.
J. P. Posti, M. Bori, T. Kauko, et al., “Presenting symptoms of glioma in adults,” Acta Neurol. Scand., 131, No. 2, 88–93 (2015), https://doi.org/10.1111/ane.12285.
F. H. Gilles, E. Sobel, A. Leviton, et al., “Epidemiology of seizures in children with brain tumors. The Childhood Brain Tumor Consortium,” J. Neurooncol., 12, No. 1, 53–68 (1992), https://doi.org/10.1007/BF00172457.
J. Kennedy and S. U. Schuele, “Long-term monitoring of brain tumors: when is it necessary?” Epilepsia, 54, Suppl. 9, 50–55 (2013), https://doi.org/10.1111/epi.12444.
M. Klein, N. H. Engelberts, H. M. van der Ploeg, et al., “Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life,” Ann. Neurol., 54, No. 4, 514–520 (2003), https://doi.org/10.1002/ana.10712.
B. V. Martynov, V. E. Parfenov, G. E. Trufanov, et al., “Prognostic factors in patients with gliomas: symptom-syndrome analysis,” Vestn. Ross. Voenno-Med. Akad., No. 1, 7–14 (2010).
C. Vecht, L. Royer-Perron, C. Houillier, and G. Huberfeld, “Seizures and anticonvulsants in brain tumours: frequency, mechanisms and anti-epileptic management,” Curr. Pharm. Des., 23, No. 42, 6464–6487 (2017), https://doi.org/10.2174/1381612823666171027130003.
X. Fan, Y. Li, X. Shan, et al., “Seizures at presentation are correlated with better survival outcomes in adult diffuse glioma: A systematic review and meta-analysis,” Seizure, 59, 16–23 (2018), https://doi.org/10.1016/j.seizure.2018.04.018.
M. Yu. Prokudin, M. M. Odinak, I. V. Litvinenko, et al., “Magnetic resonance spectroscopy in cerebral gliomas: biological markers.” Doctor. Ru, No. 1, 10–15 (2018).
G. Kaloshi, D. Psimaras, K. Mokhtari, et al., “Supratentorial low-grade gliomas in older patients,” Neurology, 73, No. 24, 2093–2098 (2009), https://doi.org/10.1212/wnl.0b013e3181c6781e.
E. Olafsson and W. A. Hauser, “Prevalence of epilepsy in rural Iceland: a population-based study,” Epilepsia, 40, No. 11, 1529–1534 (1999), https://doi.org/10.1111/j.1528-1157.1999.tb02036.x.
A. B. Guekht, “Epidemiology and economic aspects of epilepsy,” Zh. Nevrol. Psikhiatr., 105, No. 8, 63–65 (2005).
M. S. van Breemen, E. B. Wilms, and C. J. Vecht, “Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management,” Lancet Neurol., 6, No. 5, 421–430 (2007), https://doi.org/10.1016/S1474-4422(07)70103-5.
P. L. Moots, R. J. Maciunas, D. R. Eisert, et al., “The course of seizure disorders in patients with malignant gliomas,” Arch. Neurol., 52, No. 7, 717–724 (1995), https://doi.org/10.1001/archneur.1995.00540310091021.
A. Rigamonti, F. Imbesi, A. Silvani, et al., “Pattern of care and outcome in elderly patients with glioblastoma: Data in 151 patients from 3 Lombardia Hospitals,” J. Neurol. Sci., 378, 3–8 (2017), https://doi.org/10.1016/j.jns.2017.04.030.
N. K. Aaronson, M. J. Taphoorn, J. J. Heimans, et al., “Compromised health-related quality of life in patients with low-grade glioma,” J. Clin. Oncol., 29, No. 33, 4430–4435 (2011), https://doi.org/10.1200/JCO.2011.35.5750.
M. Klein, M. J. Taphoorn, J. J. Heimans, et al., “Neurobehavioral status and health-related quality of life in newly diagnosed highgrade glioma patients,” J. Clin. Oncol., 19, No. 20, 4037–4047 (2001), https://doi.org/10.1200/JCO.2001.19.20.4037.
K. L. Chaichana, S. L. Parker, A. Olivi, and A. Quinones-Hinojosa, “Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article,” J. Neurosurg., 111, No. 2, 282–292 (2009), https://doi.org/10.3171/2009.2.JNS081132.
M. Kerkhof and C. J. Vecht, “Seizure characteristics and prognostic factors of gliomas,” Epilepsia, 54, Supplement 9, 12–17 (2013), https://doi.org/10.1111/epi.12437.
X. Su, H. L. Chen, Z. Y. Wang, et al., “Relationship between tumour location and preoperative seizure incidence in patients with gliomas: a systematic review and meta-analysis,” Epileptic Disord., 17, No. 4, 397–408 (2015), https://doi.org/10.1684/epd.2015.0788.
C. Huang, H. Li, M. Chen, et al., “Factors associated with preoperative and postoperative epileptic seizure in patients with cerebral ganglioglioma,” Pak. J. Med. Sci., 30, No. 2, 245–249 (2014), https://doi.org/10.12669/pjms.302.4362.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 120, No. 11, Iss. 1, pp. 22–28, November, 2020.
Rights and permissions
About this article
Cite this article
Prokudin, M.Y., Odinak, M.M., Litvinenko, I.V. et al. Clinical-Morphological Risk Factors for the Development of Epilepsy in Patients with Glial and Metastatic Brain Tumors. Neurosci Behav Physi 51, 867–872 (2021). https://doi.org/10.1007/s11055-021-01145-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-021-01145-8